These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1747139)

  • 1. Continuous removal of anti-DNA antibody, using a new extracorporeal immunoadsorption system, in patients with systemic lupus erythematosus.
    Suzuki K; Hara M; Harigai M; Ishizuka T; Hirose T; Matsuki Y; Kawaguchi Y; Kitani A; Kawagoe M; Nakamura H
    Arthritis Rheum; 1991 Dec; 34(12):1546-52. PubMed ID: 1747139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of immunoadsorption using dextran-sulfate cellulose columns in the treatment of systemic lupus erythematosus.
    Suzuki K
    Ther Apher; 2000 Jun; 4(3):239-43. PubMed ID: 10910027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-avidity anti-DNA antibody removal from the serum of systemic lupus erythematosus patients by adsorption using dextran sulfate cellulose columns.
    Matsuki Y; Suzuki K; Kawakami M; Ishizuka T; Kawaguchi Y; Hidaka T; Nakamura H
    J Clin Apher; 1996; 11(1):30-5. PubMed ID: 8722720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic selective adsorption of anti-DNA antibody using dextran sulfate cellulose column (Selesorb) for the treatment of systemic lupus erythematosus.
    Kutsuki H; Takata S; Yamamoto K; Tani N
    Ther Apher; 1998 Feb; 2(1):18-24. PubMed ID: 10227784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-dsDNA antibody kinetics during in vivo apheresis in systemic lupus erythematosus patients and in an in vitro apheresis model.
    Suzuki K; Taman J; Matsuki Y; Hidaka T; Ishizuka T; Kawakami M; Yabuki T; Kutsuki H; Nakamura H
    J Clin Apher; 1996; 11(4):211-6. PubMed ID: 8986867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective removal of anti-double-stranded DNA antibodies by immunoadsorption with dextran sulphate in a patient with systemic lupus erythematosus.
    Kinoshita M; Aotsuka S; Funahashi T; Tani N; Yokohari R
    Ann Rheum Dis; 1989 Oct; 48(10):856-60. PubMed ID: 2479345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apheresis enhances the selective removal of antinuclear antibodies in systemic lupus erythematosus.
    Colburn KK; Gusewitch GA; Statian Pooprasert BS; Weisbart RH
    Clin Rheumatol; 1990 Dec; 9(4):475-82. PubMed ID: 2088644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-DNA antibody kinetics following selective removal by adsorption using dextran sulphate cellulose columns in patients with systemic lupus erythematosus.
    Suzuki K; Matsuki Y; Hidaka T; Ishizuka T; Kawakami M; Takata S; Kutsuki H; Nakamura H
    J Clin Apher; 1996; 11(1):16-22. PubMed ID: 8722717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The course of anticardiolipin antibody levels under immunoadsorption therapy.
    Hauser AC; Hauser L; Pabinger-Fasching I; Quehenberger P; Derfler K; Hörl WH
    Am J Kidney Dis; 2005 Sep; 46(3):446-54. PubMed ID: 16129206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adsorption of anaphylatoxins from the plasma of systemic lupus erythematosus patients using dextran sulfate cellulose columns.
    Matsuki Y; Suzuki K; Kawakami M; Ishizuka T; Hidaka T; Nakamura H
    J Clin Apher; 1998; 13(3):108-13. PubMed ID: 9828020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity anti-DNA antibody parallels clinical course of immunoadsorption therapy for systemic lupus erythematosus.
    Funauchi M; Ikoma S; Enomoto H; Ohno M; Kinoshita K; Horiuchi A; Kurata N
    Intern Med; 1996 May; 35(5):367-72. PubMed ID: 8797048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective removal of anti-DNA and anticardiolipin antibodies by adsorbent plasmapheresis using dextran sulfate columns in patients with systemic lupus erythematosus.
    Hashimoto H; Tsuda H; Kanai Y; Kobayashi S; Hirose S; Shinoura H; Yokohari R; Kinoshita M; Aotsuka S; Yamada H
    J Rheumatol; 1991 Apr; 18(4):545-51. PubMed ID: 2066947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal removal of anti-DNA antibodies in systemic lupus erythematosus using DNA-collagen films.
    Laville M; el Habib R; Traeger J; Coulet PR; Gautheron DC; Sanhadji K; My H; Zech PY
    Life Support Syst; 1983; 1 Suppl 1():65-70. PubMed ID: 6400735
    [No Abstract]   [Full Text] [Related]  

  • 14. Dextran sulfate (Selesorb) plasma apheresis improves vascular changes in systemic lupus erythematosus.
    Braun N; Jünger M; Klein R; Gutenberger S; Guagnin M; Risler T
    Ther Apher; 2002 Dec; 6(6):471-7. PubMed ID: 12460414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
    Biesenbach P; Schmaldienst S; Smolen JS; Hörl WH; Derfler K; Stummvoll GH
    Atheroscler Suppl; 2009 Dec; 10(5):114-21. PubMed ID: 20129388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption.
    Amital H; Heilweil-Harel M; Ulmansky R; Harlev M; Toubi E; Hershko A; Naparstek Y
    Rheumatology (Oxford); 2007 Sep; 46(9):1433-7. PubMed ID: 17686790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous anti-dsDNA antibody apheresis in systemic lupus erythematosus.
    Suzuki K; Hara M; Ishizuka T; Hirose T; Harigai M; Kitani K; Kawagoe M; Nakamura H
    Lancet; 1990 Sep; 336(8717):753-4. PubMed ID: 1975926
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effectiveness of specific removal of anti-DNA antibodies in vivo--an application of anti-DNA antibody immunoadsorption in NZBxNZW F1 hybrid mice].
    Kiyohara A
    Nihon Hifuka Gakkai Zasshi; 1988 Jun; 98(7):689-95. PubMed ID: 3074188
    [No Abstract]   [Full Text] [Related]  

  • 19. A new device for specific extracorporeal immunoadsorption of anti-DNA antibodies. In vitro and in vivo results.
    Traeger J; Laville M; Serres PF; Cronenberger M; Thomas M; Rey MJ; Bourgeat C
    Ann Med Interne (Paris); 1992; 143 Suppl 1():9-12. PubMed ID: 1300896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential adsorption of cationic anti-DNA antibodies with immobilized polyanionic compounds, dextran sulfate.
    Suzuki N; Otuka I; Harada T; Mizushima Y; Sakane T
    Autoimmunity; 1994; 19(2):105-12. PubMed ID: 7772700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.